Fed cuts rates, halts balance-sheet runoff to shore up labor market and market functioning amid economic uncertainty.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed cuts rates, halts balance-sheet runoff to shore up labor market and market functioning amid economic uncertainty.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.